Intco Medical Technology Co., Ltd. (SHE:300677)
China · Delayed Price · Currency is CNY 35.73
-0.90 (-2.46%)
Aug 14, 2025, 2:45 PM CST
Intco Medical Technology Revenue
Intco Medical Technology had revenue of 2.49B CNY in the quarter ending March 31, 2025, with 13.20% growth. This brings the company's revenue in the last twelve months to 9.81B, up 30.01% year-over-year. In the year 2024, Intco Medical Technology had annual revenue of 9.52B with 37.65% growth.
Revenue (ttm)
9.81B
Revenue Growth
+30.01%
P/S Ratio
2.43
Revenue / Employee
893.66K
Employees
10,982
Market Cap
23.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.52B | 2.60B | 37.65% |
| Dec 31, 2023 | 6.92B | 304.91M | 4.61% |
| Jan 1, 2023 | 6.61B | -9.63B | -59.27% |
| Jan 1, 2022 | 16.24B | 2.40B | 17.37% |
| Dec 31, 2020 | 13.84B | 11.75B | 564.29% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 29.19B |
| Shenzhen Mindray Bio-Medical Electronics | 35.59B |
| WuXi AppTec | 41.48B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
| Aier Eye Hospital Group | 21.81B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Shanghai United Imaging Healthcare | 10.43B |
| Yunnan Baiyao Group Co.,Ltd | 40.10B |